Back to Trials
NCT06681818NARecruiting

Novel Method to Assess Hepatic Regeneration and Predict Hepatic Related Morbidity After Partial Hepatectomy

Englewood Hospital and Medical Center

Start Date

11/21/2025

Completion Date

1/1/2039

Summary

the investigators will pursue two specific aims: (1) to monitor the extent of heme oxygenase induction (by measuring endogenous CO production) in relationship to the extent of hepatic resection (2) to assess the production of CO in patients following liver resection and correlate these findings to the rate of liver regeneration and liver function.

Eligibility Criteria

Age Range: 18 years to No maximum

Inclusion Criteria: * Patient plans to have partial liver resection for primary liver pathology or metastatic disease * Patient is able to comprehend and willing to sign the written consent form Exclusion Criteria: * Patients \< 18 years * Patients identified as members of a vulnerable population, except women of child bearing potential with negative pregnancy test

Interventions

OTHER

carbon monoxide measurement via smokerlyzer

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

Liver Cancer AdultLiver Regeneration

Locations

Englewood Hospital

Englewood, New Jersey 07631

United States